Status:
COMPLETED
Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
Lead Sponsor:
Chong-Jin Kim
Collaborating Sponsors:
Hanmi Pharmaceutical Company Limited
Conditions:
Hypertension
Eligibility:
All Genders
19-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate which combination therapy is more effective for improving the blood pressure (BP) and AM central SBP in hypertensive patients:Angiotensin II receptor blocke...
Eligibility Criteria
Inclusion
- Hypertension patients not included exclusion criteria
- Mean seated SBP ≥140mmHg in patients with newly Diagnosed
Exclusion
- \- msDBP≥110mmHg or ms SBP ≥ 180mmHg at the screening and randomization visit
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2016
Estimated Enrollment :
231 Patients enrolled
Trial Details
Trial ID
NCT02294539
Start Date
August 1 2014
End Date
May 18 2016
Last Update
March 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kyung Hee University Hospital at Gangdong
Seoul, South Korea